跳至主要内容
临床试验/NL-OMON51901
NL-OMON51901尚未招募不适用

ong-term pain modulation by intravenous esketamine in Complex Regional Pain Syndrome: a non-inferiority study - KetCRPS-2

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Age >= 18 years.
  • - Meeting the new International Association for the Study of Pain (IASP)
  • diagnostic criteria for CRPS (*the Budapest Criteria) or having met the new
  • IASP diagnostic criteria of CRPS (*CRPS with Remission of Some features*)
  • (Harden et al. 2010) (Goebel et al. 2021)
  • - Willing and capable to participate in the study.
  • - CRPS in one upper extremity and/or CRPS in one lower extremity
  • - Treatment in an elective setting.
  • - Adequate comprehension of the Dutch language

排除标准

  • Contraindications to and precautions for use of subanesthetic doses of ketamine
  • for chronic pain are listed by Cohen et al. and the Dutch CRPS guidelines and
  • our clinical protocol (Cohen et al. 2018; Perez et al. 2014). For each patient,
  • the contraindications and precautions for use of esketamine infusions for CRPS
  • patients will be checked/assessed by their treating pain specialist. If a
  • patient has no contraindications for esketamine treatment and the patient is
  • eligible for esketamine treatment according to the Dutch CRPS guidelines, the
  • patient will be placed on the waiting list. In this study we only select
  • patients from the waiting list for esketamine treatment of the Center for Pain

研究者

相似试验

ong-term pain modulation by intravenous esketamine... | 临床试验